Literature DB >> 15836891

The metabolic syndrome.

Robert H Eckel1, Scott M Grundy, Paul Z Zimmet.   

Abstract

The metabolic syndrome is a common metabolic disorder that results from the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated. A proinflammatory state probably contributes to the syndrome. The increased risk for type 2 diabetes and cardiovascular disease demands therapeutic attention for those at high risk. The fundamental approach is weight reduction and increased physical activity; however, drug treatment could be appropriate for diabetes and cardiovascular disease risk reduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15836891     DOI: 10.1016/S0140-6736(05)66378-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  1610 in total

1.  Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats.

Authors:  Maria L Justo; Rosalia Rodriguez-Rodriguez; Carmen M Claro; Maria Alvarez de Sotomayor; Juan Parrado; Maria D Herrera
Journal:  Eur J Nutr       Date:  2012-06-04       Impact factor: 5.614

Review 2.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

3.  Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.

Authors:  Luisa Costa; Francesco Caso; Roberta Ramonda; Antonio Del Puente; Luca Cantarini; Md Abud Darda; Paolo Caso; Mariagrazia Lorenzin; Ugo Fiocco; Leonardo Punzi; Raffaele Scarpa
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 4.  Oxidative tissue: perilipin 5 links storage with the furnace.

Authors:  Hong Wang; Carole Sztalryd
Journal:  Trends Endocrinol Metab       Date:  2011-05-31       Impact factor: 12.015

5.  Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.

Authors:  Fernanda M Consolim-Colombo; Carine T Sangaleti; Fernando O Costa; Tercio L Morais; Heno F Lopes; Josiane M Motta; Maria C Irigoyen; Luiz A Bortoloto; Carlos Eduardo Rochitte; Yael Tobi Harris; Sanjaya K Satapathy; Peder S Olofsson; Meredith Akerman; Sangeeta S Chavan; Meggan MacKay; Douglas P Barnaby; Martin L Lesser; Jesse Roth; Kevin J Tracey; Valentin A Pavlov
Journal:  JCI Insight       Date:  2017-07-20

6.  A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.

Authors:  Md Abdul Hye Khan; Lauren Kolb; Melissa Skibba; Markus Hartmann; René Blöcher; Ewgenij Proschak; John D Imig
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

7.  Effect of Caloric Restriction on Metabolic Dysfunction of Young Rapacz Familial Hypercholesterolemic Swine (Sus scrofa).

Authors:  Nell A Bekiares; Andrea S Chen; Dhanansayan Shanmuganayagam; Adrienne Dardenne Meyers; Thomas D Crenshaw; Christian G Krueger; Jess D Reed
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 9.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

10.  Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators.

Authors:  Ling Yang; Ping Li; Wenjing Yang; Xiangbo Ruan; Kurtis Kiesewetter; Jun Zhu; Haiming Cao
Journal:  Cell Metab       Date:  2016-09-22       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.